(-)-Pindolol and (±)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors

Neuropharmacology

Volumn 35, Issue 2, 1996, Pages 213-222

  Assie, M B ^a   Koek, W ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

( ) pindolol; ( ) tertatolol; 5 HT1A receptor; 5 HT1B receptor; Hippocampus; Microdialysis

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; CITALOPRAM; MIANSERIN; PINDOLOL; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; TERTATOLOL; PROPANOLAMINE DERIVATIVE; SEROTONIN RECEPTOR; THIOPHENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; LIGAND BINDING; MALE; MICRODIALYSIS; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BETAXOLOL; HIPPOCAMPUS; MALE; MICRODIALYSIS; PINDOLOL; PROPANOLAMINES; RATS; RECEPTORS, SEROTONIN; SEROTONIN; THIOPHENES;

EID: 0029670492     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-3908(95)00169-7     Document Type: Article

References (41)

1. Adell A., Carceller A. and Artigas F. (1993) In vivo brain dialysis study of the somatodendritic release of serotonin in the raphe nuclei of the rat: effects of 8-hydroxy-2-(di-n-propylamino)tetralin. J. Neurochem. 60: 1673-1681.
2. 1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Eur. J. Pharmac. 264: 259-264.
3. Assié M.-B. and Koek W. (1994) Effects of (S)WAY 100135 on 5-HT levels in the ventral hippocampus of anaesthetized rat as measured by in vivo microdialysis. In: Monitoring Molecules in Neuroscience: Proceedings of the 6th Conference on in vivo Methods (Louilot A., Durkin T., Spampinato U. and Cador M., Eds), pp. 193-194. Publi Typ, Gradignan, France.
4. 1A agonist 8-OH-DPAT: a microdialysis study. Br. J. Pharmac. 114: 356P.
5. 1A antagonist pindolol. In: Monitoring Molecules in Neuroscience: Proceedings of the 6th International Conference on In Vivo Methods (Louilot A., Durkin T., Spampinato U. and Cador M., Eds), pp. 209-210. Publi Typ, Gradignan, France.
6. Bosker F. J., Donker M. G., Klompmakers A. A., Kurata K. and Westenberg H. G. M. (1994) 5-Hydroxytryptamine release in dorsal hippocampus of freely moving rats: modulation by pindolol. Prog. Neuropsychopharmac. Biol. Psychiatry 18: 765-778.
7. 1B/D receptor ligands. Pharmac. Ther. 62: 385-405.
8. 1B receptors modulate serotonin efflux in the rat dorsal raphe nucleus. In: Monitoring Molecules in Neurosciences: Proceedings of the 6th Conference on In Vivo Methods (Louilot A., Durkin T., Spampinato U. and Cador M., Eds), pp. 195-196. Publi Typ, Gradignan, France.
9. 1B binding sites. Naunyn-Schmiedeberg's Archs Pharmac. 332: 1-7.
10. 1A receptors. Eur. J. Pharmac. 237: 283-291.
11. 1A receptor antagonist. Proceedings of the 5-HT Third IUPHAR Satellite p. 91. Chicago, U.S.A.
12. 1A receptor antagonist WAY-100635 on hippocampal 5-HT release in vivo. Br. J. Pharmac. 112: 299P.
13. Hjorth S. and Carlsson A. (1986) Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors? Eur. J. Pharmac. 129: 131-138.
14. 1A receptors: behavioural and in vivo brain microdialysis studies. Life Sci. 46: 955-963.
15. 1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. Life Sci. 48: 1779-1786.
16. 1B autoreceptor block-ing properties of the beta adrenoceptor antagonist (-)penbutolol. J. Pharmac. Exp. Ther. 265: 707-712.
17. 1A receptors in the rat brain. Naunyn-Schmiedeberg's Archs Pharmac. 347: 453-463.
18. 1B receptor-binding studies in rat brain membranes. J. Neurochem. 58: 1268-1276.
19. 1A autoreceptors by chronic administration of 8-OH-DPAT. Neuropharmacology 31: 1073-1076.
20. 1A receptors in vivo. Eur. J. Pharmac. 240: 307-310.
21. 1A agonists. Molec. Pharmac. 37: 231-237.
22. 1 receptor agonist, RU 24969, inhibits the efflux of 5-hydroxytryptamine from rat frontal cortex slices by stimulation of the 5-HT autoreceptor. J. Pharm. Pharmac. 37: 434-437.
23. Middlemiss D. N. (1986) Blockade of the central 5-HT autoreceptor by β-adrenoceptor antagonists. Eur. J. Pharmac. 120: 51-56.
24. 1B like receptor and antagonism by methiothepin. Neuropharmacology 33: 67-75.
25. Paxinos G. and Watson C. (1986) The Rat Brain In Stereotaxic Coordinates (2nd ed.). Academic Press, New York.
26. 1A) receptor antagonist in rat brain. J. Pharmac. Exp. Ther. 265: 739-744.
27. 1A) receptors in the anticonflict activity of β-adrenoceptor antagonists. Pharmac. Biochem. Behav. 47: 873-878.
28. Routledge C. and Marsden C. A. (1985) Application of high performance liquid chromatography with electrochemical detection to the study of neurotransmitters in vivo. Biochem. Soc. Trans. 13: 1058-1061.
29. 1A receptor antagonist WAY100135: an in vivo microdialysis study. Eur. J. Pharmac. 239: 195-202.
30. 1A) receptors. Psychopharmacology 108: 85-92.
31. 1D receptors mediating inhibition of adenylate cyclase activity: pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonists. Naunyn-Schmiedeberg's Archs Pharmac. 340: 285-292.
32. 1A autoreceptor. J. Neurosci. Meth. 34: 83-90.
33. Sharp T., Bramwell S. R., Clark D. and Grahame-Smith D. G. (1989a) In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity. J. Neurochem. 53: 234-240.
34. Sharp T., Bramwell S. R., Hjorth S. and Grahame Smith D. G. (1989b) Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. Br. J. Pharmac. 98: 989-997.
35. 1A antagonist, BMY 7378. Eur. J. Pharmac. 176: 331-340.
36. 1A receptor agents using a composite pharmacophore analysis and chemical database screening. Naunyn-Schmiedeberg's Archs Pharmac. 343: 109-116.
37. Sleight A. J., Marsden C. A., Martin K. F. and Palfreyman M. G. (1988) Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan. Br. J. Pharmac. 93: 303-310.
38. 1B agonists. Synapse 1: 3-9.
39. 1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphé nucleus. Neuropharmacology 33: 393-402.
40. Struyker Boudier H. and Abbott A. (1989) Novel antihypertensive drug reveals unexpected complexities in beta-adrenoceptor pharmacology. Trends Pharmac. Sci. 10: 469-471.
41. VanderMaelen C. P., Matheson G. K., Wilderman R. C. and Patterson L. A. (1986) Inhibition of serotoninergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. Eur. J. Pharmac. 129: 123-130.